Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 2 1

Status

Completed 4Terminated 2Recruiting 2Withdrawn 1Active not recruiting 1

Sponsor Class

INDUSTRY 5OTHER 4NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Tumor-Agnostic 1Other hematologic neoplasm 1Breast 1

Conditions

Neoplasm Metastasis 1Leukemia, Myeloid, Acute 1Breast Cancer Metastatic 1Advanced Cancer 1

Interventions

Cyclophosphamide 956Radiotherapy 847Cisplatin 757Gemcitabine 657Carboplatin 603Docetaxel 598Paclitaxel 585Bevacizumab 580Fluorouracil 504Oxaliplatin 458Rituximab 453Surveys and Questionnaires 449Capecitabine 440Dexamethasone 428Doxorubicin 424Etoposide 411Irinotecan 389Cytarabine 376Filgrastim 369pembrolizumab 330Leucovorin 305Nivolumab 296fludarabine phosphate 294Melphalan 288Magnetic Resonance Spectroscopy 281Peripheral Blood Stem Cell Transplantation 279Blood Specimen Collection 279Methotrexate 276Lenalidomide 276Cetuximab 270

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × OTHER × Liposomes × Clear all
NCT04915612 2026-05-20

Liposomal Cytarabine, Daunorubicin, and Gemtuzumab Ozogamicin for the Treatment of Relapsed Refractory Pediatric Patients With Acute Myeloid Leukemia

M.D. Anderson Cancer Center

Phase 1 Completed
1 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT03328884 2025-04-23

Phenomenal

MedSIR

Phase 2 Completed
55 enrolled
Breast

Breast Cancer Metastatic

NCT00761644 2019-04-11

Doxil, Bevacizumab and Temsirolimus Trial

M.D. Anderson Cancer Center

Phase 1 Completed
200 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT00507962 2012-08-02

Cisplatin HAI Study in Patients With Advanced Cancer and Dominant Liver Involvement

M.D. Anderson Cancer Center

Phase 1 Completed
51 enrolled

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡